//www.makeeyeware.comInsight
//www.makeeyeware.comTaplow
//www.makeeyeware.comKnowledge
  • News
  • 案例
  • 下载
国际高管搜索Taplow C必威平台官网onsulting法国通过临时管理扩展其服务。
17.12.2018

国际高管搜索Taplow C必威平台官网onsulting法国通过临时管理扩展其服务。

For nearly 10 years, two human resources consulting firms, Taplow Consulting France, expert in Executive Search, coaching and management...
Read more
The Taplow Group S.A. at the briefing on the Real Estate markets with the focus on the 2019 outlook hosted by CBRE and Investment Briefings
13.12.2018

The Taplow Group S.A. at the briefing on the Real Estate markets with the focus on the 2019 outlook hosted by CBRE and Investment Briefings

Mark Firth, Managing Partner - UK and Chairman of The Taplow Group S.A

Read more
27.08.2018

Taplow India, Managing Partner and Taplow Group, Asia Regional Director appears in the Economic Times, India.

Sangeeta Sabharwal，Taplow India执行伙伴和Taplow集团亚洲区域总监作为《经济时报》，印度...
Read more
First 9 10 11 12 13 14 15 16 17 18 Last

CEO FOR A SPORTS:

Situation: A Finnish, mainly nationally operating sports company needed new CEO as the old one was about to retire. As sports business is one of the competence areas of our Finnish partner, we ended up delivering this search.

阅读更多 …

For further Information please contac芬兰的蒂莫·托瓦宁（Timo Toivanen）

CEO FOR LOGISTICS:

Situation: One of the largest globally operating Logistics companies was in a need of new CIO for Finland. As Logistics and Value Chain is one of the competence areas of our Finnish partner, we ended up delivering this search.

阅读更多 …

For further Information please contac芬兰的蒂莫·托瓦宁（Timo Toivanen）

White Papers

  • 印度 - 新型汽车的研发枢纽

    Taplow India have conducted an in-depth review of the Automotive sector in India, For further information contactSangeeta Sabharwal, India

    Click Here

  • Maysam Rizvi reviews the Banking Tech Revolution.

    Capital is more expensive, costs are higher and prices have gone down… the technology revolution has become a necessity.

    Click Here

  • EVOLVING BUSINESS UNITS Market Access thus becoming “transversal”

    The pharmaceutical market, in regards to the price component covered by the NHS, has been, until today, characterised by the presence of drugs of high therapeutic value, such as cancer-drugs, rheumatologic drugs, anti-infection drugs and drugs for the treatment of chronic illnesses, the vast majority of which have either seen their patent expire recently or will see it expire in the next two years.

    Click Here

  • BUSINESS CYCLES

    人力资本提供了机遇和挑战:

    Click Here